Overview

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Status:
Completed

Trial end date:
2017-01-09

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety, effectiveness and tolerance of low doses of oral naltrexone along with buprenorphine to treat opioid use disorder prior to the first injection of VIVITROL.

Phase:

Phase 3

Details

Lead Sponsor:

Alkermes, Inc.

Treatments:

Analgesics, Opioid
Buprenorphine
Naltrexone